Losmapimod Completed Phase 2 Trials for Chronic Obstructive Pulmonary Disease (COPD) Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01541852Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen.